Integral Health Asset Management’s Quest Diagnostics DGX Stock Holding History

Integral Health Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.8M	Sell	60,000 -15,000	-20%	-$2.91M	0.56%	46
2025 Q4	$13M	Sell	75,000 -10,000	-12%	-$1.82M	0.65%	52
2025 Q3	$16.2M	Sell	85,000 -65,000	-43%	-$11.5M	1.1%	25
2025 Q2	$26.9M	Buy	+150,000	New	+$26.1M	2.47%	9
2025 Q1	–	Sell	-130,000	Closed	-$19.6M	–	90
2024 Q4	$19.6M	Buy	130,000 +10,000	+8%	+$1.56M	1.67%	19
2024 Q3	$18.6M	Buy	120,000 +20,000	+20%	+$2.99M	2.1%	14
2024 Q2	$13.7M	Buy	+100,000	New	+$13.7M	1.3%	25
2023 Q1	–	Sell	-100,000	Closed	-$15.6M	–	76
2022 Q4	$15.6M	Buy	+100,000	New	+$14.4M	3.28%	6
2020 Q3	–	Sell	-120,000	Closed	-$13.7M	–	78
2020 Q2	$13.7M	Hold	120,000	–	–	4.1%	2
2020 Q1	$9.64M	Buy	120,000 +40,000	+50%	+$4.14M	4.24%	5
2019 Q4	$8.54M	Buy	+80,000	New	+$8.34M	3.33%	11

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Integral Health Asset Management's DGX Position: Q1 2026 in Review

Integral Health Asset Management reduced its Quest Diagnostics (DGX) stake by 20% in Q1 2026, selling an estimated $2.91M and leaving 60,000 shares worth $11.8M. The position accounts for 0.56% of the portfolio, ranked #46.

Integral Health Asset Management first reported a position in DGX in Q4 2019 and has held it in 11 quarters since. The position peaked at $26.9M in Q2 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Integral Health Asset Management held 60,000 shares of Quest Diagnostics worth $11.8M as of Q1 2026.
Integral Health Asset Management sold 15,000 Quest Diagnostics shares in Q1 2026, an estimated $2.91M.
Quest Diagnostics made up 0.56% of Integral Health Asset Management's portfolio in Q1 2026, its #46 holding.
Integral Health Asset Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 11 quarters since.
Integral Health Asset Management's Quest Diagnostics position peaked at $26.9M in Q2 2025.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.